GEMAYEL GEORGES sold 44.8% of their position (10.79K shares) of SUPERNUS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $391.6K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/12/2024ACC: 0001628280-24-047145
Director
Since Feb 2026
-10.79K
Net shares
Net seller
$391.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
10.79K acquired · 21.57K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+10.79K
Price / share
$11.46
Trade value
$123.62K
% of position
81.0%
11/8/2024
13.31K→24.10K
Common Stock
Direct
Shares
−10.79K
Price / share
$36.30
Trade value
$391.57K
% of position
44.8%
11/8/2024
24.10K→13.31K
Total
Net shares
+0.00
Net value
-$267.95K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/8/2024 | M · Option Exercise | +10.79K | $11.46 | $123.62K | 81.0% | 13.31K | 24.10K |
| Common Stock Direct | 11/8/2024 | S · Sale | −10.79K | $36.30 | $391.57K | 44.8% | 24.10K | 13.31K |
| Total | +0.00 | -$267.95K | ||||||
Derivative Transactions1
Director Stock Option (Right to Buy)
Direct
Converts to
Common Stock
10.79K shares
Shares
−10.79K
Strike price
11.46
Held after
0.00
Exercisable
—
11/8/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Director Stock Option (Right to Buy) Direct | Common Stock10.79K shares | 11/8/2024 | M · Option Exercise | −10.79K | 11.46 | — | 0.00 |